Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 9/20 | 0.45 |
| ▸ | ALDH2 | P05091 | 4/20 | 0.45 |
| ▸ | ALDH3A1 | P30838 | 4/20 | 0.45 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | HTT | P42858 | 1/20 | 0.42 |
| ▸ | CHRM5 | P08912 | 2/20 | 0.38 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.37 |
| ▸ | CASP3 | P42574 | 1/20 | 0.36 |
| ▸ | CCKBR | P32239 | 1/20 | 0.36 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.36 |
| ▸ | PTPRC | P08575 | 2/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18954534 | 0.89 | ALDH1A1 (0.50) | ALDH1A1HSD17B10MAPTHTTAGTR1 | |
| SCHEMBL18954597 | 0.82 | ALDH1A1 (0.62) | ALDH1A1ALDH2ALDH3A1HSD17B10MAPT | |
| SCHEMBL11959136 | 0.80 | ALDH1A1 (0.53) | ALDH1A1ALDH2ALDH3A1MAPTAGTR1 | |
| SCHEMBL18954738 | 0.77 | PARK7 (0.50) | ALDH1A1ALDH2ALDH3A1HSD17B10MAPT | |
| SCHEMBL18954832 | 0.77 | APAF1 (0.48) | ALDH1A1ALDH2ALDH3A1HSD17B10MAPT | |
| SCHEMBL18954763 | 0.76 | ALDH1A1 (0.71) | ALDH1A1HSD17B10MAPTHTTAGTR1 | |
| SCHEMBL18954835 | 0.75 | ALDH1A1 (0.52) | ALDH1A1ALDH3A1HSD17B10MAPTHTT | |
| SCHEMBL18954452 | 0.75 | ALDH1A1 (0.52) | ALDH1A1ALDH3A1HSD17B10MAPTHTT | |
| SCHEMBL18954706 | 0.75 | ALDH1A1 (0.43) | ALDH1A1HSD17B10MAPTHTTCHRM5 | |
| SCHEMBL18955361 | 0.74 | ALDH1A1 (0.51) | ALDH1A1HSD17B10MAPTHTTCHRM5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2017099695-A1 | N-[(AMINOSULFONYL)PHENYL]-2-(1,2-DIHYDRO-2-OXO-3H-INDOL-3-YLIDENE)-HYDRAZINECARBOTHIOAMIDE DERIVATIVES FOR TREATING CANCER AND IMMUNOLOGICAL DISORDERS | ISTANBUL UNIVERSITESI REKTORLUGU (TR) | 2017-06-15 | — | — | WO | disclosed |